Related Experiment Video
Updated: Apr 27, 2026

Assessment of Stress Effects on Cognitive Flexibility using an Operant Strategy Shifting Paradigm
Published on: May 4, 2020
Carbonyl stress and schizophrenia
Makoto Arai1, Mitsuhiro Miyashita, Akiko Kobori
1Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Schizophrenia treatment may improve by identifying a subtype characterized by carbonyl stress. This subtype shows elevated pentosidine and depleted pyridoxal, offering potential biomarkers for personalized medicine.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Schizophrenia's complex pathophysiology and heterogeneity hinder effective treatment.
- Current antipsychotics manage positive symptoms but not cognitive dysfunction or negative symptoms.
- Idiopathic carbonyl stress, indicated by methylglyoxal, contributes to protein modification and advanced glycation end products.
Purpose of the Study:
- To define a schizophrenia subtype based on carbonyl stress.
- To investigate pentosidine and pyridoxal as potential biomarkers for this subtype.
- To explore carbonyl stress as a target for personalized schizophrenia treatment.
Main Methods:
- In vitro and in vivo studies were conducted.
- Analysis of plasma pentosidine accumulation and serum pyridoxal depletion.
- Identification of a specific subpopulation of schizophrenia patients exhibiting these markers.
Main Results:
- A subpopulation of schizophrenia patients demonstrated idiopathic carbonyl stress.
- This group showed elevated plasma pentosidine and depleted serum pyridoxal.
- Pentosidine and pyridoxal levels may distinguish this specific schizophrenia subgroup.
Conclusions:
- Carbonyl stress defines a potential subtype of schizophrenia.
- Pentosidine and pyridoxal serve as promising biomarkers for this subtype.
- Targeting carbonyl stress could lead to more personalized and effective schizophrenia treatments.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
Psychoneuroimmunology: Diabetes and Cancer
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...

